Kameo, a leader in innovative health-tech solutions, has launched its COVID Management SaaS Platform.
Whether using a third-party testing partner or managing testing in-house, Kameo’s platform helps those in the entertainment industry manage COVID on film and television sets across the nation.
Kameo’s COVID management platform enables productions to schedule, test, track vaccination statuses digitally, and create a customized COVID-19 management program to keep casts and crews safe.
Over 375 productions have already administered more than 315,000 COVID-19 tests through Kameo for partners including Netflix, Disney, Sony Pictures, Viacom, Legendary, and HBO.
The company’s most recent roll-out will make their suite of services available across the United States for better COVID-19 management within the entertainment industry.
Kameo’s user base currently exceeds 50,000 people on the platform. The company has worked with A24 Productions, which has produced hundreds of feature films with renowned actors including Tom Hanks, Julianne Moore, Emma Thomspon, and many others in California and across the United States.
One of the most recognized platforms for the Film & TV Industry, Kameo was also named Inc.’s Best in Business for Pandemic Response in 2021 and is now recognized as Hollywood’s most trusted testing partner.
The SaaS health-tech platform offers a suite of comprehensive tools designed to simplify the management of otherwise complex testing schedules, vaccination statuses, results reporting, customized self-assessment questionnaires, and more in light of the COVID-19 pandemic.
The company’s platform includes:
● Schedule Testing
● Track Testing in Real-Time
● Daily Health Questionnaire
● Vaccination Tracking
● Results Reporting
● Track Billing
● Messaging Via Email + Text Message
● Manage Self-Administered Test Kits
Kameo, which also offers bulk at-home antigen and PCR tests with seamless platform integration, was developed as a response to the entertainment industry’s need for systemized health tracking in light of COVID-19. The company is female and veteran-founded, with a mission to simplify the health and safety of the set, cast, and crew on film and television productions throughout the US.
No one knows the importance of getting film and television production back to a pre-pandemic state more than President and Founder of Kameo Alex Ostebo.
“Today, COVID management is essential at all levels in the entertainment industry,” she says. “Our SaaS platform enables decision-makers to seamlessly monitor COVID on set while preserving each individual’s confidentiality and privacy.”
Kameo’s services are twofold. The testing vertical leverages over 200 nurses, a fleet of mobile tests, and a network of 30 high-throughput PCR labs for efficient onsite testing with rapid results across the United States.
The company provides all necessary staffing to conduct testing procedures and deploys mobile labs anywhere that sets film nationwide. Additionally, a team of professionals are available onsite to manage check-in, scheduling, results analysis, and more.
The centralized, secure, HIPAA-compliant platform protects sensitive PHI & VIP privacy with robust technical safeguards that monitor systems and security roles.
“Our platform has become an integral part of COVID management on film and TV sets across the nation. We are excited to make it more accessible so that more productions can benefit from the system we’ve built,” says Matt Hibberd, CEO of Kameo. “We’re constantly improving and optimizing our platform as the state of the pandemic evolves – and that is one of the reasons our platform has gained trust and adoption within the entertainment industry.”